Atrial fibrillation in intensive care units

Current Anaesthesia and Critical Care

Volumn 17, Issue 6, 2006, Pages 367-374

  Cavaliere, Franco ^a   Volpe, Carmen ^a   Soave, Maurizio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Atrial fibrillation; Intensive care units; Postoperative complications

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; IBUTILIDE; POLYSORBATE 80; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

AGE; ANTICOAGULATION; ARTICLE; CARDIOMYOPATHY; CHRONIC LUNG DISEASE; CORNEA DISEASE; DISORDERS OF ACID BASE BALANCE; ELECTROLYTE DISTURBANCE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEMOCHROMATOSIS; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOTENSION; HYPOTHYROIDISM; HYPOVOLEMIA; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LIVER DYSFUNCTION; LIVER INJURY; LIVER TOXICITY; LUNG FIBROSIS; LUNG INJURY; MITRAL VALVE DISEASE; NEUROMUSCULAR DISEASE; PERIOPERATIVE PERIOD; PHOTOSENSITIVITY; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; RISK FACTOR; SEPSIS; THROMBOPHLEBITIS; THYROTOXICOSIS; TREATMENT CONTRAINDICATION; VALVULAR HEART DISEASE;

EID: 34247139220     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2006.12.002     Document Type: Article

References (62)

1. Cameron A., Schwartz M.J., Kronmal R.A., and Kosinski A.S. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 61 (1988) 714-717
2. Cairns J.A., and Connolly S.J. Nonrheumatic atrial fibrillation. Risks of stroke and role of antithrombotic therapy. Circulation 84 (1991) 469-481
3. Almassi G.H., Schowalter T., Nicolosi A.C., et al. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg 226 (1997) 501-511
4. Nattel S., Hadjis T., and Talajic M. The treatment of atrial fibrillation: an evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 48 (1994) 345-371
5. Ara A. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127 (2004) 779-786
6. Reinelt P., Karth G.D., Geppert A., et al. Incidence and type of cardiac arrhythmias in critically ill patients: a single centre experience in a medical cardiological ICU. Intensive Care Med 27 (2001) 1466-1473
7. Seguin P., Laviolle B., Maurice A., et al. Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med 32 (2006) 398-404
8. Ommen S.R. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 336 (1997) 1429-1434
9. Aranki S.F., Shaw D.P., Adams D.H., et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94 (1996) 390-397
10. Tisdale JE, Pharm D. Clinical trials. Gov identifier=NCT00127712 (317): prevention of atrial fibrillation following noncardiac thoracic surgery, 2004.
11. Christians K.K., Wu B., Quebbeman E.J., et al. Postoperative atrial fibrillation in noncardiothoracic surgical patients. Am J Surg 182 (2001) 713-715
12. Creswell L.L. Hazards of postoperative atrial arrhythmias. Ann Thor Surg 56 (1993) 539-549
13. Miguel A. Obesity as a risk factor for developing postoperative atrial fibrillation. Chest 129 (2006) 828-829
14. Zacharias A. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation 112 (2005) 3247-3255
15. Pritchett A.M. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 41 (2003) 1036-1043
16. Knotzer H., Mayr A., Ulmer H., et al. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med 26 (2000) 908-914
17. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrythmias. Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
18. Gaudino M., Andreotti F., Zamparelli R., et al. The -174 GC interleukin 6 polymorphism influences postoperative interleukie 6 levels and postoperative atrial fibrillation. Is trial fibrillation an inflammatory complication?. Circulation 108 Suppl. II (2003) 195-199
19. Amar D., Zhang H., Heerdt P.M., et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128 (2005) 3421-3427
20. Alison A. Risk factor interactions and genetic effects associated with post-operative atrial fibrillation. Pac Symp Biocomput 11 (2006) 584-595
21. Amar D. Strategies for perioperative arrhythmias. Best Pract Res Clin Anaesthesiol 18 (2004) 565-577
22. Iseri L.T., Allen B.J., Ginkel M.L., and Brodsky M.A. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 53 (1992) 709-712
23. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41 (2003) 2185-2192
24. Wolff L. Familiar auricular fibrillation. N Engl J Med 229 (1943) 396-402
25. Fox C.S., Parise H., D'Agostino Sr. R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. J Am Med Assoc 291 (2004) 2851-2855
26. Chen Y.H., Xu S.J., Bendahhou S., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299 (2003) 251-254
27. Yang Y., Xia M., Jin Q., et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 75 (2004) 899-905
28. Xia M., Jin Q., Bendahhou S., et al. A Kir2.1 gain-of-function mutation underlies familiar atrial fibrillation. Biochem Biophys Res Commun 332 (2005) 1012-1019
29. Yamashita T., Hayami N., Ajiki K., et al. Is ACE gene polymorphism associated with lone atrial fibrillation?. Jpn Heart J 38 (1997) 637-641
30. Nathanson M.H., and Gajraj N.M. The perioperative management of atrial fibrillation. Anaesthesia 53 (1998) 665-676
31. Schamroth L. An introduction to electrocardiography (1982), Blackwell Scientific Pubblications, Oxford
32. Fisher C.M. Embolism in atrial fibrillation. In: Kulbertus H.E., Olsson S.B., and Schlepper M. (Eds). Atrial fibrillation (1982), AB Hassle, Molndal, Sweden 192-210
33. Hirosawa K., Sekiguchi M., Kasanuki H., et al. Natural history of atrial fibrillation. Heart Vessels Suppl. 2 (1987) 14-23
34. Channer K.S., and Jones J.V. Atrial systole: its role in normal and diseased hearts. Clin Sci 75 (1988) 1-4
35. Benchimol A., Ellis J.G., and Dimond E.G. Hemodynamic consequences of atrial and ventricular pacing in patients with normal and abnormal hearts. Am J Med 53 (1965) 911-922
36. Kuo L.C., Quinones M.A., Rokey R., Sartori M., Abinader E.G., and Zoghbi W.A. Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts. Am J Cardiol 53 (1987) 1174-1178
37. Greenberg B., Chatterjee K., Parmley W.W., Werner J.A., and Holly A.N. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 53 (1979) 742-751
38. Van Gelder I.C., Crijns H.J., Blanksma P.K., et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 53 (1993) 560-566
39. Rawles J.M. What is meant by a "controlled" ventricular rate in atrial fibrillation?. Br Heart J 63 (1990) 157-161
40. Atwood J.E., Myers J., Sullivan M., et al. The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation. Am Heart J 118 (1989) 913-918
41. Shapiro W., and Klein J. Alterations in cardiac function immediately following electrical cardioversion of atrial fibrillation to normal sinus rhythm. Circulation 38 (1968) 1074-1084
42. O'Neil P.G., Puleo P.R., Bolli R., and Rokey R. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J 120 (1990) 353-359
43. Shapiro E.P., Effron M.B., Lima S., Ouyang P., Siu C.O., and Bush D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 62 (1988) 1202-1207
44. Manning W.J., Leeman D.E., Gotch P.J., and Come P.C. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13 (1989) 617-623
45. Lown B., Amarasingham R., and Neuman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. J Am Med Assoc 182 (1962) 548-555
46. Lown B., Perlroth M.G., Kaidbey S., Abe T., and Harken D.E. "Cardioversion" of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients. N Engl J Med 269 (1963) 325-331
47. Nolan JP. European resuscitation council guidelines for resuscitation 2005. 6751, S1-6.
48. Van Gelder I.C., Crijns H.J., Van Gilst W.H., Verwer R., and Lie K.I. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 68 (1991) 41-46
49. Van Gelder I.C., Crijns H.J., Van der Laarse A., Van Gilst W.H., and Lie K.I. Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter. Am Heart J 121 (1991) 51-56
50. McKeown P.P., and Gutterman D. Executive summary. American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 (2005) 1S-5S
51. Martinez E.A., Bass E.B., and Zimetbau P. Pharmacologic control of rhythm. American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 (2005) 48S-55S
52. Martinez E.A., Epstein A.E., and Bass E.B. Pharmacologic control of ventricular rate. American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 (2005) 56S-60S
53. Groban L., and Butterworth J. Perioperative management of chronic heart failure. Anesth Analg 103 (2006) 557-575
54. Salpeter S., Ormiston T., and Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4 (2005) CD003566
55. Masini E., Planchenault J., Pezziardi F., Gautier P., and Gagnol J.P. Histamine-releasing properties of polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog. Agents Actions 16 (1985) 470-477
56. Balser J.R. The rational use of intravenous amiodarone in the perioperative period. Anesthesiology 86 (1997) 42-48
57. Gold R.L., Haffajee C.I., Charos G., Sloan K., Baker S., and Alpert J.S. Amiodarone for refractory atrial fibrillation. Am J Cardiol 148 (1986) 124-127
58. Skroubis G., Galiatsou E., Metafratzi Z., et al. Amiodarone-induced acute lung toxicity in an ICU setting. Acta Anaesthesiol Scand 49 4 (2006) 569-571
59. Van Mieghem W., Coolen L., Malysse I., et al. Amiodarone and the development of ARDS after lung surgery. Chest 105 (1994) 1642-1645
60. Ratz Bravo A.E., Drewe J., Schlienger R.G., et al. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med 33 (2005) 128-134
61. Bjerkelund C.J., and Orning O.M. The efficacy of anticoagulation therapy in preventing embolism related to DC electrical cardioversion of atrial fibrillation. Am J Cardiol 23 (1969) 208-216
62. Carerj S., Calabro M.P., and Di Rosa S. Atrio-auricular mechanical dissociation following electrical cardioversion for atrial fibrillation. Heart 88 (2002) 626